Towards gene therapy of MPS-I: overcoming the hurdles of anti-IDUA immunity

被引：0
|
作者：
Squeri, G. [1 ]
Ferro, F. [1 ]
Biffi, A. [1 ]
Annoni, A. [1 ]
Gregori, S. [1 ]
机构：
[1] San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P222
引用
收藏
页码：A113 / A113
页数：1
相关论文
共 50 条
  • [1] Linkage disequilibrium between IDUA kpnI-VNTR haplotype in Mexican patients with MPS-I
    Gallegos-Arreola, M
    Rivas-Solis, F
    Flores-Martínez, S
    Zúñiga-González, G
    Sandoval-Ramírez, L
    Cantú-Garza, JM
    Ranaji, C
    Figuera, L
    Morán-Moguel, MC
    Corona, JS
    ARCHIVES OF MEDICAL RESEARCH, 1999, 30 (05): : 375 - 379
  • [2] MULTIPLE POLYMORPHISMS WITHIN THE ALPHA-L-IDURONIDASE GENE (IDUA) - IMPLICATIONS FOR A ROLE IN MODIFICATION OF MPS-I DISEASE PHENOTYPE
    SCOTT, HS
    NELSON, PV
    LITJENS, T
    HOPWOOD, JJ
    MORRIS, CP
    HUMAN MOLECULAR GENETICS, 1993, 2 (09) : 1471 - 1473
  • [3] Comparison of intraventricular vs. endovascular AAV5 mediated IDUA gene delivery to the brain in the MPS-I mouse model
    Janson, Christopher
    Nan, Crusoe
    Belur, Lalitha
    Mclvor, Scott
    Low, Walter
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S22 - S22
  • [4] ENZYME REPLACEMENT THERAPY IN FELINE MUCOPOLYSACCHARIDOSIS-I (MPS-I)
    HASKINS, ME
    KAKKIS, ED
    WAN, Q
    WEIL, MA
    AGUIRRE, GD
    SCHUCHMAN, EH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 194 - 194
  • [5] Modeling and Modulating Anti-Transgene Immune Response in Ex-Vivo Gene Therapy for Mucopolysaccharidosis Type-I (MPS-I)
    Squeri, Giorgia
    Ferro, Francesca
    Aiuti, Alessandro
    Bernardo, Maria Ester
    Gentner, Bernhard
    Annoni, Andrea
    Biffi, Alessandra
    Gregori, Silvia
    MOLECULAR THERAPY, 2018, 26 (05) : 456 - 456
  • [6] Anti-IDUA IgG alters cortical bone structure of mucopolysaccaridosis type I mice treated with intravenous enzyme replacement therapy
    Hurt, Sarah
    Le, Steven Q.
    Kan, Shih-Hsin
    Brodt, Michael
    Dickson, Patricia I.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [7] Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease
    Squeri, Giorgia
    Passerini, Laura
    Ferro, Francesca
    Laudisa, Cecilia
    Tomasoni, Daniela
    Deodato, Federica
    Donati, Maria Alice
    Gasperini, Serena
    Aiuti, Alessandro
    Bernardo, Maria Ester
    Gentner, Bernhard
    Naldini, Luigi
    Annoni, Andrea
    Biffi, Alessandra
    Gregori, Silvia
    MOLECULAR THERAPY, 2019, 27 (07) : 1215 - 1227
  • [8] Validation of IDUA Gene Sequencing Using KAPA2G Robust DNA Polymerase as a Tool for Confirmation of Mucopolysaccharidosis Type I (MPS-I) via a "Single Protocol PCR"
    Majumdar, R.
    McDonald, A.
    Matern, D.
    Gavrilov, D.
    Oglesbee, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 650 - 650
  • [9] Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy
    Nagree, Murtaza S.
    Lopez-Vasquez, Lucia
    Medin, Jeffrey A.
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (11): : 1233 - 1250
  • [10] Characterization of an immunodeficient mucopolysaccharidosis type I (MPS-I) mouse model suitable for preclinical testing of human stem cell and gene therapy.
    Quito-Rivera, MF
    Colvin-Wanshura, LE
    Nelson, MS
    Nan, ZH
    Khan, SA
    Rogers, TB
    Maitra, I
    Low, WC
    Gupta, P
    BLOOD, 2005, 106 (11) : 368A - 368A
12345